Harrow (HROW) EBT Margin (2013 - 2026)

Harrow's (HROW) quarterly EBT Margin came in at 62.39% in Q1 2026, down 2521.0% year-on-year from 2.58% in Q1 2025, and down 634.6% quarter-over-quarter from 11.67% in Q4 2025.

Harrow (HROW) EBT Margin (2013 - 2026) Analysis & Trends

Harrow's EBT Margin history runs 14 years deep, the most recent figure standing at 62.39% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 2521.0% year-over-year to 62.39% in Q1 2026; TTM through Mar 2026 was 4.16%, a 596.0% increase from a year earlier, with the FY2025 full-year figure at 0.5%, up 817.0% from the prior year.
  • EBT Margin fell to 62.39% in Q1 2026 per HROW's latest filing, from 11.67% in the prior quarter.
  • Across five years, EBT Margin topped out at 11.67% in Q4 2025 and bottomed at 62.39% in Q1 2026.
  • The 5-year median for EBT Margin is 11.89% (2024), against an average of 15.51%.
  • Across the five-year window, EBT Margin surged 4128 bps in 2022 and tumbled 3182 bps in 2023, its largest moves.
  • Year by year, EBT Margin stood at 5.19% in 2022, then plunged by 613 bps to 26.63% in 2023, then surged by 135 bps to 9.37% in 2024, then climbed by 25 bps to 11.67% in 2025, then slumped by 635 bps to 62.39% in 2026.
  • Per Business Quant, the three latest HROW EBT Margin figures stand at 62.39% (Q1 2026), 11.67% (Q4 2025), and 1.42% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn -62.39%

Historic Data

Download Data
DateValue
Mar 31, 2026 -62.39%
Dec 31, 2025 11.67%
Sep 30, 2025 1.42%
Jun 30, 2025 7.84%
Mar 31, 2025 -37.17%
Dec 31, 2024 9.37%
Sep 30, 2024 -8.53%
Jun 30, 2024 -11.89%
Mar 31, 2024 -39.22%
Dec 31, 2023 -26.63%
Sep 30, 2023 -8.32%
Jun 30, 2023 -12.68%
Mar 31, 2023 -26.55%
Dec 31, 2022 5.19%
Sep 30, 2022 -28.17%
Jun 30, 2022 -26.58%
Mar 31, 2022 -11.02%
Dec 31, 2021 -36.09%
Sep 30, 2021 -44.51%
Jun 30, 2021 -13.66%